Cargando…

State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease

BACKGROUND: The Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) is used to assess decline in memory, language, and praxis in Alzheimer's disease (AD). METHODS: A latent state–trait model with autoregressive effects was used to determine how much of the ADAS‐Cog item meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cogo‐Moreira, Hugo, Krance, Saffire H., Wu, Che‐Yuan, Lanctôt, Krista L., Herrmann, Nathan, Black, Sandra E., MacIntosh, Bradley J., Rabin, Jennifer S., Eid, Michael, Swardfager, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040491/ https://www.ncbi.nlm.nih.gov/pubmed/36994227 http://dx.doi.org/10.1002/trc2.12376

Ejemplares similares

Questioning the Meaning of a Change on the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over Time
por: Cogo-Moreira, Hugo, et al.
Publicado: (2020)

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease
por: Bawa, Kritleen K., et al.
Publicado: (2020)

New scoring methodology improves the sensitivity of the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials
por: Verma, Nishant, et al.
Publicado: (2015)

Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach
por: Ruthirakuhan, Myuri, et al.
Publicado: (2022)

The Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review
por: Kueper, Jacqueline K., et al.
Publicado: (2018)

Dynamic relationships between depressive symptoms and insulin resistance over 20 years of adulthood
por: Wu, Che-Yuan, et al.
Publicado: (2023)

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
por: Wu, Che‐Yuan, et al.
Publicado: (2020)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021)

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial
por: Rockwood, Kenneth, et al.
Publicado: (2007)

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
por: Ouk, Michael, et al.
Publicado: (2021)

Validity of the QUADAS-2 in Assessing Risk of Bias in Alzheimer's Disease Diagnostic Accuracy Studies
por: Venazzi, Alisson, et al.
Publicado: (2018)

Sleep and Attention in Alzheimer’s Disease
por: Hennawy, Mirna, et al.
Publicado: (2019)

Saving cognitive outcome data in Alzheimer's disease clinical trials during the COVID‐19 pandemic: Commentary on the virtual administration of the ADAS‐Cog
por: Schwab, Nadine A., et al.
Publicado: (2020)

Peripheral inflammatory markers indicate microstructural damage within periventricular white matter hyperintensities in Alzheimer's disease: A preliminary report
por: Swardfager, Walter, et al.
Publicado: (2017)

Cardiopulmonary Fitness Correlates with Regional Cerebral Grey Matter Perfusion and Density in Men with Coronary Artery Disease
por: MacIntosh, Bradley J., et al.
Publicado: (2014)

Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
por: Wu, Che‐Yuan, et al.
Publicado: (2022)

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease
por: Benhabib, Hadas, et al.
Publicado: (2013)

Exploring Visual Selective Attention towards Novel Stimuli in Alzheimer's Disease Patients
por: Chau, Sarah A., et al.
Publicado: (2015)

White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease
por: Desmarais, Philippe, et al.
Publicado: (2021)

Post-stroke Fatigue and Depressive Symptoms Are Differentially Related to Mobility and Cognitive Performance
por: MacIntosh, Bradley J., et al.
Publicado: (2017)

Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies
por: Podhorna, Jana, et al.
Publicado: (2016)

Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation
por: Santiago, Calvin, et al.
Publicado: (2017)

24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone
por: Ruthirakuhan, Myuri, et al.
Publicado: (2019)

Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study
por: Behl, Pearl, et al.
Publicado: (2014)

ADAS-viewer: web-based application for integrative analysis of multi-omics data in Alzheimer’s disease
por: Han, Seonggyun, et al.
Publicado: (2021)

Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling
por: Ueckert, Sebastian, et al.
Publicado: (2014)

Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
por: Ruthirakuhan, Myuri T., et al.
Publicado: (2019)

A new Brief computerized cognitive screening battery (CompCogs) for early diagnosis of Alzheimer’s disease
por: Fichman, Helenice Charchat, et al.
Publicado: (2008)

Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis
por: Chen, Jinghan Jenny, et al.
Publicado: (2022)

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease
por: Liu, Celina S., et al.
Publicado: (2020)

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate
por: van Dyck, Christopher H., et al.
Publicado: (2020)

Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
por: Dowlati, Yekta, et al.
Publicado: (2010)

Effects of GV1001 on Language Dysfunction in Patients With Moderate-to-Severe Alzheimer’s Disease: Post Hoc Analysis of Severe Impairment Battery Subscales
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Kynurenine and depressive symptoms in a poststroke population
por: Bensimon, Kira, et al.
Publicado: (2014)

Diabetes Mellitus Is Associated With Poor In‐Hospital and Long‐Term Outcomes in Young and Midlife Stroke Survivors
por: MacIntosh, Bradley J., et al.
Publicado: (2021)

The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment
por: Gold, Allison B, et al.
Publicado: (2011)

Burden of Illness in People with Alzheimer’s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
por: Lanctôt, Krista L., et al.
Publicado: (2023)

The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis
por: Dinoff, Adam, et al.
Publicado: (2016)

Higher Cortisol Predicts Less Improvement in Verbal Memory Performance after Cardiac Rehabilitation in Patients with Coronary Artery Disease
por: Saleem, Mahwesh, et al.
Publicado: (2013)

Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study
por: Clark, Emily D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n15mdh3i4ffklavbpbkds8m8l0